SCHEMBL17423729

SCHEMBL17423729

O=Cc1ccc(Oc2cccnc2)cc1F

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.56
TDP1 Q9NUW8 1/20 0.56
CYP19A1 P11511 3/20 0.51
NPC1 O15118 1/20 0.45
GAA P10253 1/20 0.45
HPGD P15428 1/20 0.45
RAB9A P51151 1/20 0.45
ERN1 O75460 1/20 0.45
HTT P42858 1/20 0.44
FFAR4 Q5NUL3 2/20 0.43
ORAI1 Q96D31 1/20 0.42
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
HRH3 Q9Y5N1 1/20 0.41
LTA4H P09960 1/20 0.40
ALDH1A1 P00352 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20523126 0.88 LMNA (0.56) LMNATDP1CYP19A1NPC1GAA
SCHEMBL1134294 0.84 LMNA (0.57) LMNATDP1CYP19A1ERN1HTT
SCHEMBL31167043 0.82 LMNA (0.56) LMNATDP1CYP19A1ERN1HTT
SCHEMBL26980167 0.81 SOS1 (0.38) LMNAERN1ALDH1A1SMN1; SMN2
SCHEMBL23709919 0.81 LMNA (0.50) LMNATDP1NPC1GAARAB9A
SCHEMBL433463 0.80 ALDH1A1 (0.58) LMNATDP1CYP19A1GAAERN1
SCHEMBL11111298 0.79 ERN1 (0.58) LMNATDP1CYP19A1ERN1HTT
SCHEMBL15903722 0.79 ALDH1A1 (0.35) ALDH1A1
SCHEMBL12260750 0.77 LMNA (0.61) LMNATDP1CYP19A1NPC1GAA
SCHEMBL12330285 0.77 LMNA (0.61) LMNATDP1CYP19A1NPC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016007837-A1 CARBONYL LINKED BICYCLIC HETEROARYL ANTIBIOTIC TOLERANCE INHIBITORS SPERO THERAPEUTICS, INC. (US) 2016-01-14 WO disclosed
WO-2016007837-A1 CARBONYL LINKED BICYCLIC HETEROARYL ANTIBIOTIC TOLERANCE INHIBITORS SPERO THERAPEUTICS, INC. (US) 2016-01-14 WO disclosed